Alnylam Pharmaceuticals Total Long-Term Assets 2010-2024 | ALNY

Alnylam Pharmaceuticals total long-term assets for the quarter ending September 30, 2024 were $0.850B, a 0.47% decline year-over-year.

  • Alnylam Pharmaceuticals total long-term assets for 2023 were $0.847B, a 0.81% decline from 2022.
  • Alnylam Pharmaceuticals total long-term assets for 2022 were $0.854B, a 2.32% increase from 2021.
  • Alnylam Pharmaceuticals total long-term assets for 2021 were $0.835B, a 5.36% increase from 2020.

Alnylam Pharmaceuticals Total Long-Term Assets 2010-2024 | ALNY

  • Alnylam Pharmaceuticals total long-term assets for 2023 were $0.847B, a 0.81% decline from 2022.
  • Alnylam Pharmaceuticals total long-term assets for 2022 were $0.854B, a 2.32% increase from 2021.
  • Alnylam Pharmaceuticals total long-term assets for 2021 were $0.835B, a 5.36% increase from 2020.